The most interesting potential prostate cancer biomarker identified in our study (both at 100% specificity and combined specificity and sensitivity) is TM256/C17orf61, a protein that has been predicted to be located at the plasma membrane [38] and in exosomes [29]. This evidence concerns the gene TMEM256 and prostate carcinoma.